Second Allogeneic Stem Cell Transplantation: A Mortality Analysis
ALANI, M.; BOURHIS, J. H.
Show abstract
Second allogeneic stem cell transplantation was realized in 48 patients with myeloid and lymphoid neoplasms at Gustave Roussy institute since 1987. Overall survival rate was about 30 % with better outcome in acute myeloid leukemia cases. Non-relapse related mortality is overwhelming, especially in myelodysplasia patients and despite the fact that complete remission was obtained in their majority. Graft versus Host disease is very common after second transplantation with many grade III - IV cases and one death from severe pulmonary GvHD lesions. Reduced intensity conditioning is certainly less toxic and together with optimal GvHD and infectious disease management, Second SCT may be a reasonable therapeutic option and the only curative treatment for many hematological malignancies.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population 94%
- Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA) 94%
- LRRC33 is a novel binding and regulating protein of TGF-β1 function in human acute myeloid leukemia cells 93%
Similar papers in this journal
- HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway 91%
- Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning 91%
- Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population 91%
Similar papers in this journal
- Stratified computational meta-analysis of 2213 acute myeloid leukemia patients reveals age- and sex-dependent gene expression signatures 93%
- Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors 92%
- Development of Small Molecule MEIS Inhibitors that modulate HSC activity 91%
Similar papers in this journal
- Risk and Outcome of Second primary malignancy in patients with classical Hodgkin lymphoma 92%
- Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India 89%
- Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study 88%
Similar papers in this journal
- Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19) 91%
- Exploring the role of Large Language Models (LLMs) in hematology: a systematic review of applications, benefits, and limitations 90%
- Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.